Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer

April 9, 2015 updated by: Northwestern University

Effect of Weight Loss on Breast Density Using Both Digital Mammography and Breast MRI

Diagnostic procedures, such as digital mammography and MRI, may help measure how weight loss affects breast density in women who are at increased risk for breast cancer.

Study Overview

Detailed Description

OBJECTIVES: I. To determine if weight loss in patients undergoing Roux en Y gastric bypass procedures has any effect on breast density as measured by mammography and breast MRI. OUTLINE: GROUP I: Participants undergo mammography and MRI at baseline and 1 year. Participants also undergo gastric bypass surgery. GROUP II: Participants undergo mammography and MRI at baseline and 1 year. After completion of study treatment, patients are followed up at 1 year.

Study Type

Observational

Enrollment (Actual)

43

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Pre-menopausal women between the ages of 30 and 50 who are eligible and undergoing evaluation for gastric bypass surgery

Description

Inclusion Criteria:

  • Women eligible for gastric bypass surgery
  • Pre-menopausal women
  • All women will have signed an informed consent form prior to participating in study procedures

Exclusion Criteria:

  • Women with a history of breast cancer
  • Women currently taking exogenous hormone replacement therapy
  • Women currently taking a SERM
  • Women currently taking an aromatase inhibitor
  • Pregnant or lactating women
  • Women who have been pregnant or lactating in the past 2 years
  • Women who have metallic or other surgical implants
  • All subjects will have a determination of their estimated glomerular filtration rate (eGFR) within 24 hours of undergoing any study where gadolinium based contrast agents will be administered
  • Subjects should not have a known history of recent onset acute renal dysfunction
  • Subjects with a history of stable chronic renal dysfunction may participate in studies using GBCA based on their eGFR, as outlined below
  • Subjects should not have severe liver dysfunction, particularly when associated with kidney disease
  • Subjects should receive GBCAs in the perioperative period (i.e. within 4 weeks) after renal or liver transplantation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
Participants who are eligible for and have opted to undergo gastric bypass surgery
Undergo MRI at baseline and 1 year later.
Other Names:
  • MRI
  • NMRI
  • nuclear magnetic resonance imaging
  • NMR imaging
Undergo digital mammography at baseline and 1 year later.
Undergo gastric bypass surgery
Other Names:
  • surgery, conventional
Group 2
Participants who are eligible for but decided not to undergo gastric bypass surgery.
Undergo MRI at baseline and 1 year later.
Other Names:
  • MRI
  • NMRI
  • nuclear magnetic resonance imaging
  • NMR imaging
Undergo digital mammography at baseline and 1 year later.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in BMI and breast density
Time Frame: At baseline and year 1
At baseline and year 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nora Hansen, Northwestern University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

July 1, 2014

Study Completion (Actual)

July 1, 2014

Study Registration Dates

First Submitted

December 10, 2010

First Submitted That Met QC Criteria

December 10, 2010

First Posted (Estimate)

December 13, 2010

Study Record Updates

Last Update Posted (Estimate)

April 10, 2015

Last Update Submitted That Met QC Criteria

April 9, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NU 10B01
  • STU00038177 (Other Identifier: Northwestern University IRB)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy, no Evidence of Disease

Clinical Trials on magnetic resonance imaging

Subscribe